Sandoz mobilises critical medicine production in Europe
European Pharmaceutical Review
NOVEMBER 15, 2023
The company has the “only major remaining vertically-integrated production network for penicillins in Europe”; thus the new European facilities will play an important role in maintaining adequate supply of these medicines. The company stated that the new site will create approximately 200 new full-time jobs once the facility is opened.
Let's personalize your content